{{Rsnum
|rsid=7723605
|Chromosome=5
|position=5354502
|Orientation=plus
|GMAF=0.2695
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.1 | 23.1 | 73.8
| HCB | 15.6 | 48.9 | 35.6
| JPT | 13.3 | 37.8 | 48.9
| YRI | 24.2 | 37.1 | 38.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 15.6 | 48.9 | 35.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

Originally reported to be one of 13 SNPs found in whole genome association study to be associated with [[Parkinson's disease]]. However, neither it (nor the other 13) appeared to be associated with [[Parkinson's disease]] in an independent study of 663 Caucasian patients.{{PMID|18280617}}

{{PMID|16252231|OA=1
}} High-resolution whole-genome association study of Parkinson disease.

{{PMID|16685661|OA=1
}} Genomewide association, Parkinson disease, and PARK10.

{{PMID|16685662|OA=1
}} No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

{{PMID|16685663|OA=1
}} A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}